Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.48 -0.01 (-2.02%)
As of: Sep 30, 2026 · 12:36 PM EDT

Pasithea Therapeutics Corp. (KTTA) EBT Margin (2022)

Updated

Pasithea Therapeutics' EBT Margin was -1683.92% in Q4 2022, up 233.23 percentage points from the prior quarter.

Analysis

Pasithea Therapeutics Corp. (KTTA) EBT Margin (2022) Analysis & Trends

For FY2022, EBT Margin at Pasithea Therapeutics came in at -2410.37%, up 12020.12 percentage points from FY2021.

  • In earlier years, EBT Margin was -14430.49% in FY2021.
  • Per Business Quant data, KTTA's EBT Margin in the three quarters before Q4 2022 was -1917.15% (Q3 2022), -16124.43% (Q2 2022) and -11526.14% (Q1 2022).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -1,683.92%
Sep 30, 2022 -1,917.15%
Jun 30, 2022 -16,124.43%
Mar 31, 2022 -11,526.14%
API Access

Pasithea Therapeutics Corp. EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=KTTA&period=max&api_key=YOUR_API_KEY